Alison Haggerty advises innovative private and public companies and leading financial institutions across a broad range of corporate and securities matters.

Ali brings particular experience handling complex capital markets transactions, including initial public offerings, follow-on equity offerings, and convertible debt offerings. She is adept at advising on a variety of general corporate and governance matters, including disclosure obligations, securities compliance, and stock exchange rules and requirements.

Ali takes a pragmatic, solutions-oriented approach to counseling companies across industries, including technology, healthcare and life sciences, digital health, consumer retail, and energy.

Ali’s representative experience includes advising on transactions and/or general corporate matters for the following companies:

  • Abivax
  • ArriVent BioPharma
  • ADC Therapeutics*
  • Aquantia*
  • Axovant*
  • BigBear.ai
  • Cara Therapeutics*
  • Caris Life Sciences
  • Catabasis*
  • Cleerly
  • Cloudmed
  • Datadog*
  • DigitalOcean
  • Duolingo
  • Etsy*
  • European Wax Center
  • Everyday Health*
  • FIGS
  • Fluence Energy
  • Freshpet
  • Imara*
  • Immunovant*
  • J. Jill
  • Klarna
  • MongoDB*
  • Monte Rosa Therapeutics
  • Myovant Sciences*
  • ODDITY Tech
  • Ovid*
  • Prevail Therapeutics*
  • Progyny
  • RenalytixAI*
  • Rivian
  • Roivant Sciences
  • Schrodinger*
  • SKIMS
  • Strongbridge Biopharma*
  • StubHub
  • Thorne HealthTech
  • Via Transportation
  • VillageMD
  • WAVE Life Sciences*
  • Zentalis Pharmaceuticals*
  • Zeta Global

*Client represented prior to joining Latham

Bar Qualification

  • New York

Education

  • JD, New York University School of Law, 2010
    cum laude
  • BS, University of North Carolina, Chapel Hill, 2004
Abstract blue light and shade triangle shape creative background illustration.
August 25, 2025 Recognition

Latham Leads H1 2025 Capital Markets League Tables

Firm’s Capital Markets Practice once again earns top legal advisor league table rankings across debt and equity products and industries globally in Bloomberg, Dealogic, Deal Point Data, and LSEG.

Haggerty, Alison A.
July 12, 2022 Recognition

Rising Star: Latham's Alison Haggerty

Latham & Watkins capital markets partner Alison Haggerty has steered some of the most intriguing and largest initial public offerings over the last few years, including Rivian Automotive's US$11.9 billion IPO in 2021, earning her a spot as one of the capital markets attorneys under age 40 honored by Law360 as Rising Stars.